Deppisch N[Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2013	1
2015	1
2017	1
2023	0

Page 1

Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.

Deppisch N, Ruf P, Eißler N, Lindhofer H, Mocikat R. Deppisch N, et al. Oncotarget. 2017 Jan 17;8(3):4520-4529. doi: 10.18632/oncotarget.13888. Oncotarget. 2017. PMID: 27966460 Free PMC article.

Potential of the trifunctional bispecific antibody surek depends on dendritic cells: rationale for a new approach of tumor immunotherapy.

Eissler N, Mysliwietz J, Deppisch N, Ruf P, Lindhofer H, Mocikat R. Eissler N, et al. Among authors: deppisch n. Mol Med. 2013 Apr 30;19(1):54-61. doi: 10.2119/molmed.2012.00140. Mol Med. 2013. PMID: 23552725 Free PMC article.

Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery.

Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, Mocikat R. Deppisch N, et al. Mol Cancer Ther. 2015 Aug;14(8):1877-83. doi: 10.1158/1535-7163.MCT-15-0156. Epub 2015 Jun 10. Mol Cancer Ther. 2015. PMID: 26063765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year